Contact

Menu

Thematic Equity Advisory Board

Credit Suisse Asset Management has established a Thematic Equity Advisory Board with distinguished academic and industry experts to gain specialized insights into new technologies and complement its investment management process.

On behalf of its Thematic Equity Funds, Credit Suisse Asset Management has established the Advisory Board to receive specialized insights into future technologies, strengthen its expertise in robotics, digital health and security, and position itself at the center of new developments in these fields. The Advisory Board will be an integral part of the investment process of the Thematic Equity Funds.

Members of the Advisory Board

Chair

Angus Muirhead

Angus Muirhead

Head of Equities, Head of Themes, and Senior Portfolio Manager – Credit Suisse (Lux) Robotics Equity Fund

Academia

 Prof. Dr. Roland Siegwart

Prof. Dr. Roland Siegwart

Professor for autonomous mobile robots,
ETH Zurich

Prof. Dr. David Basin

Professor for Information Security, ETH Zurich

Prof. Dr. Volker Hoffmann

Professor for Sustainability and Technology, ETH Zurich

Prof. Dr. Rahmi Oklu

Professor and Consultant, Vascular and Interventional Radiology
Director, Laboratory for Patient-Inspired Engineering
Mayo Clinic
Founder of Obsidio, Inc.
Founder of InTumo Therapeutics, Inc.

Industry experts

Dr. Gery Colombo

Dr. Gery Colombo

Founder of Hocoma

Tory Patterson

Managing Director of Owl Ventures

Dr. h.c. Mathis Wackernagel

Sustainability Analyst and Founder of Global Footprint Network

Credit Suisse representatives

Dr. Patrick Kolb

Dr. Patrick Kolb

Senior Portfolio Manager – Credit Suisse (Lux) Security Equity Fund

Holger Frey

Holger Frey

Senior Portfolio Manager – Credit Suisse (Lux) Environmental Impact Equity Fund

Thomas Amrein

Thomas Amrein

Senior Portfolio Manager – Credit Suisse (Lux) Digital Health Equity Fund

This material constitutes marketing material of UBS AG and/or its affiliates (hereafter "UBS"). This material does not constitute or form part of an offer or invitation to issue or sell, or of a solicitation of an offer to subscribe or buy, any securities or other financial instruments, or enter into any other financial transaction, nor does it constitute an inducement or incitement to participate in any product, offering or investment. This material does not constitute investment research or investment advice and may not be relied upon. It is not tailored to your individual circumstances, or otherwise constitutes a personal recommendation. The information may change after the date of this material without notice and UBS has no obligation to update the information. This material may contain information that is licensed and/or protected under intellectual property rights of the licensors and property right holders. Nothing in this material shall be construed to impose any liability on the licensors or property right holders. Unauthorized copying of the information of the licensors or property right holders is strictly prohibited. This material may not be forwarded or distributed to any other person and may not be reproduced. Any forwarding, distribution or reproduction is unauthorized and may result in a violation of the U.S. Securities Act of 1933, as amended (the “Securities Act”). The securities referred to herein have not been, and will not be, registered under the Securities Act, or the securities laws of any states of the United States and, subject to certain exceptions, the securities may not be offered, pledged, sold or otherwise transferred within the United States or to, or for the benefit or account of, U.S. persons. The only legally binding terms of any investment product described in this material, including risk considerations, objectives, charges and expenses are set forth in the prospectus, offering memorandum, subscription documents, fund contract and/or any other fund governing documents. Prospective investors should independently and carefully assess (with their tax, legal and financial advisers) the specific risks described in such materials, and applicable legal, regulatory, credit, tax and accounting consequences prior to making any investment decision.